SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-006910
Filing Date
2019-04-11
Accepted
2019-04-11 06:09:39
Documents
24
Period of Report
2019-04-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K innv20190410_8k.htm 8-K 21646
2 EXHIBIT 99.1 ex_140425.htm EX-99.1 12861
3 slide22.jpg GRAPHIC 129883
4 slide21.jpg GRAPHIC 198498
5 slide20.jpg GRAPHIC 118943
6 slide19.jpg GRAPHIC 66119
7 slide18.jpg GRAPHIC 117648
8 slide17.jpg GRAPHIC 123741
9 slide16.jpg GRAPHIC 91632
10 slide15.jpg GRAPHIC 87699
11 slide14.jpg GRAPHIC 138898
12 slide13.jpg GRAPHIC 87828
13 slide12.jpg GRAPHIC 113077
14 slide11.jpg GRAPHIC 112083
15 slide10.jpg GRAPHIC 159554
16 slide09.jpg GRAPHIC 94626
17 slide08.jpg GRAPHIC 124791
18 slide07.jpg GRAPHIC 131230
19 slide06.jpg GRAPHIC 102149
20 slide05.jpg GRAPHIC 322191
21 slide04.jpg GRAPHIC 105224
22 slide03.jpg GRAPHIC 206358
23 slide02.jpg GRAPHIC 178054
24 slide01.jpg GRAPHIC 238208
  Complete submission text file 0001437749-19-006910.txt   4236474
Mailing Address 8845 REHCO ROAD SAN DIEGO CA 92121
Business Address 8845 REHCO ROAD SAN DIEGO CA 92121 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52991 | Film No.: 19742786
SIC: 2834 Pharmaceutical Preparations